UCB Biosciences recalls
UCB Biosciences has 1 recall on record with the FDA and USDA, the earliest in 2026 and the latest reported on 27 May 2026. 1 is still ongoing. 1 was reported in the last 12 months. The most frequent reason is sterility.
Total recalls1since 2026
Last 12 months1reported
Class I00% of total
Ongoing1latest 27 May 2026
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 0 0%Class II 1 100%Class III 0 0%
Why ucb biosciences is recalled
Product types
By year
Ongoing ucb biosciences recalls
1 active| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | cimzia (certolizumab pegol), 2x200mg/mL Prefilled Syringes (-dose) recalledCimzia | UCB Biosciences | Sterility | Nationwide |
All ucb biosciences recalls, newest first
1 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | cimzia (certolizumab pegol), 2x200mg/mL Prefilled Syringes (-dose) recalledCimzia | UCB Biosciences | Sterility | Nationwide |
About this list
Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.